Trial Profile
A retrospective case report series of patients (post-marketing) Receiving Olanzapine IntraMuscular Outside of Product Monograph doses and indications: assessing safety and tolerability
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2006
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary)
- Indications Mental disorders
- Focus Adverse reactions
- Acronyms ROIMOPM
- 23 Oct 2006 Status change
- 22 Oct 2006 New trial record.